Intravenous Immunoglobulin Market Size, Growth | Forecast 2028
The intravenous immunoglobulin market was valued at US$ 11,206.54 million in 2021 and is likely to reach to a value of US$ 18,672.55 million by 2028; it is estimated to grow at a CAGR of 7.6% from 2022 to 2028.
Immunoglobulins are the antibodies produced naturally by the body’s immune system, which help fight infection and disease. The deficiency of immunoglobulin requires the external administration of immunoglobulin and is known as immunoglobulin replacement therapy (IgRT). IgRT can be given intravenously and subcutaneously. Intravenous immunoglobulin (IVIg) and subcutaneous immunoglobulin (SCIg) are selected based on the indication and severity. IVIg is manufactured from human plasma. It contains antibodies and is used to treat a growing number of immunologic, hematologic, and neurologic illnesses.
The intravenous immunoglobulin market is segmented into type, application, distribution channel, end user, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. This report offers insights and in-depth analysis of the market, emphasizing parameters, such as market trends, market dynamics, and the competitive analysis of the globally leading market players.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Intravenous Immunoglobulin Market: Strategic Insights
Market Size Value in US$ 11,206.54 Million in 2021 Market Size Value by US$ 18,672.55 Million by 2028 Growth rate CAGR of 7.6% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Intravenous Immunoglobulin Market: Strategic Insights
| Market Size Value in | US$ 11,206.54 Million in 2021 |
| Market Size Value by | US$ 18,672.55 Million by 2028 |
| Growth rate | CAGR of 7.6% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2021 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Insights
Rising prevalence of immunodeficiency diseases and increasing geriatric population is driving the intravenous immunoglobulin market.
According to the National Institute of Allergy and Infectious Diseases (NIAID), over 200 different types of primary immune deficiency diseases (PIDDs) affect about 500,000 people in the US. The rare genetic diseases can be chronic, weak, and expensive. Immune Thrombocytopenia (ITP) is an autoimmune bleeding disorder characterized by abnormally low levels of platelets; a situation referred to as thrombocytopenia. According to the Rare Diseases Organization, around 200,000 ITP cases are recorded worldwide annually. Further, according to the United Nations Population Division, World Population Prospects 2019, Asian and European countries have some of the world’s oldest populations aged 65 and over. Japan is at the top with 28%, followed by Italy at 23%. Further, Finland, Portugal, and Greece are among the top five countries with an aged population under 22%. Many of the patients treated with IVIG are above the age of 60 years. With aging, the ability to produce T-cells to fight diseases gets significantly reduced. Thus, an older person’s body is easily prone to several infections and diseases, which increases the demand for immune therapies that involve the use of IVIg. Thus, the rise in immunodeficiency diseases and increasing geriatric population across the globe is bolstering the intravenous immunoglobulin market.
Type-Based Insights
Based on the type, the intravenous immunoglobulin market is segmented into IgG, IgM, IgA, IgE, and IgD. The IgG type immunoglobulin segment held the largest market share in 2021. However, the handheld segment is anticipated to register the highest CAGR during the forecast period owing to its wide application of IgG in treating several categories of disorders.
Application-Based Insights
Based on application, the intravenous immunoglobulin market is segmented into hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy, immunodeficiency diseases, myasthenia gravis, multifocal motor neuropathy, idiopathic thrombocytopenic purpura, inflammatory myopathies, specific antibody deficiency, Guillain-Barre syndrome, and others. In 2021, the immunodeficiency diseases segment held the market's largest share. Moreover, the same segment is expected to witness growth in its demand at the fastest CAGR from 2022 to 2028 due to the rising prevalence of immunodeficiency diseases and increasing FDA approvals for IVIg products to treat immunodeficiency.
Distribution Channel-Based Insights
Based on distribution channel, the intravenous immunoglobulin market is segmented into hospital pharmacy, retail pharmacy, and others. In 2021, the hospital pharmacy segment held the largest share of the market. Further, the retail pharmacy segment is expected to witness growth in its demand at the fastest CAGR from 2022 to 2028, owing to the expansions of retail pharmacies and the shift of consumer behavior towards organized retail pharmacies that offer high-quality drugs and medicines.
End User-Based Insights
Based on end user, the intravenous immunoglobulin market is segmented into hospitals, specialty clinics, and others. In 2021, the hospitals segment held the largest share of the market. Further, the specialty clinics segment is expected to witness growth in demand at the fastest CAGR from 2022 to 2028, owing to the advances in specialty clinics for offering quick and accurate IgRT to patients.
Organic developments such as product approvals are highly adopted strategies by the global intravenous immunoglobulin market players. A few of the recent key market developments are listed below:
- In March 2022, ADMA Biologics, Inc. announced the United States Food and Drug Administration’s (FDA) approval to extend the expiration dating from 24 to 36 months for both its ASCENIV and BIVIGAM immune globulin (“IG”) drug product stored at 2-8°C. The expiration date extension applies to all existing ASCENIV and BIVIGAM lots currently in the commercial supply chain as well as to future production of ASCENIV and BIVIGAM in all vial sizes, production scales as well as internal and external fill-finished drug product.
- In June 2021, Octapharma announced that octagam 10%, a human plasma-derived intravenous immunoglobulin (IVIg), has recently been granted approval in the European Union (EU) as an immunomodulatory therapy for adults with dermatomyositis. Following the EU approval, octagam 10% received national approval in Germany on May 11, 2021, with approval in other European member states expected soon.
- In April 2021, ADMA Biologics, Inc. announced that the U.S. Food and Drug Administration (“FDA”) approved the Company’s expanded manufacturing process, enabling fractionation and purification of a 4,400-liter plasma pool for the manufacture of Intravenous Immune Globulin (“IVIG”).
- In February 2020, CSL Behring announced that the U.S. Food and Drug Administration (FDA) granted Privigen (Immune Globulin Intravenous (Human), 10% Liquid) orphan-drug designation as an investigational therapy in the treatment of Systemic Sclerosis (SSc).
Such developments by market players are driving the intravenous immunoglobulin market.
Intravenous Immunoglobulin Market Report Scope
Intravenous Immunoglobulin – Market Segmentation
The global intravenous immunoglobulin market is segmented into type, application, distribution channel, end user, and geography. Based on type, the market is segmented into IgG, IgM, IgA, IgE, and IgD). By Application, the market is segmented into hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy, immunodeficiency diseases, myasthenia gravis, multifocal motor neuropathy, idiopathic thrombocytopenic purpura, inflammatory myopathies, specific antibody deficiency, Guillain-Barre syndrome, and others. Based on distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, and others. By End User, the market is segmented into hospitals, specialty clinics, and others. By geography, the market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America.
Company Profiles
- Takeda Pharmaceutical Company Limited
- Grifols, S.A.
- Pfizer Inc.
- ADMA Biologics Inc.
- Bio Products Laboratory Ltd.
- Shanghai RAAS
- Octapharma AG
- Kedrion S.p.A
- CSL Behring (CSL Limited)
- Prothya Biosolutions B.V.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Application, Distribution Channel, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The intravenous immunoglobulin market majorly consists of the players such as Takeda Pharmaceutical Company Limited; Grifols, S.A.; Pfizer Inc.; ADMA Biologics Inc.; Bio Products Laboratory Ltd.; Shanghai RAAS; Octapharma AG; Kedrion S.p.A; CSL Behring (CSL Limited); and Prothya Biosolutions B.V.
Based on geography, the APAC region is accounted for highest CAGR in intravenous immunoglobulin market during the forecast period.
The IgG segment under type segment, held the largest share in 2021.
Immunoglobulins are the antibodies produced naturally by the body’s immune system, which help fight infection and disease. The deficiency of immunoglobulin requires the external administration of immunoglobulin and known as immunoglobulin replacement therapy (IgRT). IgRT can be given intravenously and subcutaneously. Intravenous immunoglobulin (IVIg) and subcutaneous immunoglobulin (SCIg) are selected based on the indication and severity. IVIg is manufactured from human plasma. It contains antibodies and is used in the treatment of a growing number of immunologic, hematologic and neurologic illnesses.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Intravenous Immunoglobulin Market – By Type
1.3.2 Global Intravenous Immunoglobulin Market – By Application
1.3.3 Global Intravenous Immunoglobulin Market – By Distribution Channel
1.3.4 Global Intravenous Immunoglobulin Market – By End User
1.3.5 Global Intravenous Immunoglobulin Market – By Geography
2. Intravenous Immunoglobulin Market– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Intravenous Immunoglobulin Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 South & Central America – PEST Analysis
4.2.5 Middle East & Africa – PEST Analysis
4.3 Expert Opinion
5. Intravenous Immunoglobulin Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Immunodeficiency Diseases
5.1.2 Increasing Geriatric Population
5.2 Market Restraints
5.2.1 Adverse Effects of Immunoglobulin Therapy
5.3 Market Opportunities
5.3.1 Growing Pharmaceutical Industry
5.4 Future Trends
5.4.1 Strong Pipeline Candidates for IVIG
5.5 Impact Analysis
6. Intravenous Immunoglobulin Market– Global Analysis
6.1 Global Intravenous Immunoglobulin Market Revenue Forecast and Analysis
6.2 Global Intravenous Immunoglobulin Market, By Geography - Forecast and Analysis
6.3 Global Intravenous Immunoglobulin Market – Market Potential Analysis, By Region
6.4 Company Analysis
6.4.1 Comparative Company Analysis
6.4.2 Growth Strategy Analysis
6.4.3 Performance of Key Players
6.4.3.1 Takeda Pharmaceutical Company Limited
6.4.3.2 Grifols, S.A.
7. Global Intravenous Immunoglobulin Market Revenue and Forecast to 2028– by Type
7.1 Overview
7.2 Global Intravenous Immunoglobulin Market, By Type 2022 & 2028 (%)
7.3 IgG
7.3.1 Overview
7.3.2 IgG Revenue and Forecast to 2028 (US$ Million)
7.4 IgM
7.4.1 Overview
7.4.2 IgM - Revenue and Forecast to 2028 (US$ Million)
7.5 IgA
7.5.1 Overview
7.5.2 IgA - Revenue and Forecast to 2028 (US$ Million)
7.6 IgE
7.6.1 Overview
7.6.2 IgE - Revenue and Forecast to 2028 (US$ Million)
7.7 IgD
7.7.1 Overview
7.7.2 IgD - Revenue and Forecast to 2028 (US$ Million)
8. Global Intravenous Immunoglobulin Market Revenue and Forecast to 2028 – by Application
8.1 Overview
8.2 Global Intravenous Immunoglobulin Market, By Application 2022 & 2028 (%)
8.3 Hypogammaglobulinemia
8.3.1 Overview
8.3.2 Hypogammaglobulinemia - Market Revenue and Forecast to 2028 (US$ Million)
8.4 Chronic Inflammatory Demyelinating Polyneuropathy
8.4.1 Overview
8.4.2 Chronic Inflammatory Demyelinating Polyneuropathy - Market Revenue and Forecast to 2028 (US$ Million)
8.5 Immunodeficiency Diseases
8.5.1 Overview
8.5.2 Immunodeficiency Diseases - Market Revenue and Forecast to 2028 (US$ Million)
8.6 Myasthenia Gravis
8.6.1 Overview
8.6.2 Myasthenia Gravis - Market Revenue and Forecast to 2028 (US$ Million)
8.7 Multifocal Motor Neuropathy
8.7.1 Overview
8.7.2 Multifocal Motor Neuropathy - Market Revenue and Forecast to 2028 (US$ Million)
8.8 Idiopathic Thrombocytopenic Purpura
8.8.1 Overview
8.8.2 Idiopathic Thrombocytopenic Purpura - Market Revenue and Forecast to 2028 (US$ Million)
8.9 Inflammatory Myopathies
8.9.1 Overview
8.9.2 Inflammatory Myopathies - Market Revenue and Forecast to 2028 (US$ Million)
8.10 Specific Antibody Deficiency
8.10.1 Overview
8.10.2 Specific Antibody Deficiency - Market Revenue and Forecast to 2028 (US$ Million)
8.11 Guillain-Barre Syndrome
8.11.1 Overview
8.11.2 Guillain-Barre Syndrome - Market Revenue and Forecast to 2028 (US$ Million)
8.12 Others
8.12.1 Overview
8.12.2 Others - Market Revenue and Forecast to 2028 (US$ Million)
9. Global Intravenous Immunoglobulin Market Revenue and Forecast to 2028 – by Distribution Channel
9.1 Overview
9.2 Global Intravenous Immunoglobulin Market, By Distribution Channel 2022 & 2028 (%)
9.3 Hospital Pharmacy
9.3.1 Overview
9.3.2 Hospital Pharmacy - Market Revenue and Forecast to 2028 (US$ Million)
9.4 Retail Pharmacy
9.4.1 Overview
9.4.2 Retail Pharmacy - Market Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others - Market Revenue and Forecast to 2028 (US$ Million)
10. Global Intravenous Immunoglobulin Market Revenue and Forecast to 2028 – by End User
10.1 Overview
10.2 Global Intravenous Immunoglobulin Market, By End User 2022 & 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals - Market Revenue And Forecasts To 2028 (US$ Million)
10.4 Specialty Clinics
10.4.1 Overview
10.4.2 Specialty Clinics - Market Revenue And Forecasts To 2028 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others - Market Revenue And Forecasts To 2028 (US$ Million)
11. Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 – Geographical Analysis
11.1 North America: Intravenous Immunoglobulin Market Revenue and Forecast to 2028
11.1.1 Overview
11.1.2 North America: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
11.1.3 North America: Intravenous Immunoglobulin Market, by Type, 2019–2028 (US$ Million)
11.1.4 North America: Intravenous Immunoglobulin Market, by Application, 2019–2028 (US$ Million)
11.1.5 North America: Intravenous Immunoglobulin Market, by Distribution Channel, 2019–2028 (US$ Million)
11.1.6 North America: Intravenous Immunoglobulin Market, by End User, 2019–2028 (US$ Million)
11.1.7 North America: Intravenous Immunoglobulin Market, by Country, 2022 & 2028 (%)
11.1.7.1 US: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.1 Overview
11.1.7.1.2 US: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.3 US: Intravenous Immunoglobulin Market, by Type, 2019–2028 (US$ Million)
11.1.7.1.4 US: Intravenous Immunoglobulin Market, by Application, 2019–2028 (US$ Million)
11.1.7.1.5 US: Intravenous Immunoglobulin Market, by Distribution Channel, 2019–2028 (US$ Million)
11.1.7.1.6 US: Intravenous Immunoglobulin Market, by End User, 2019–2028 (US$ Million)
11.1.7.2 Canada: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.1 Overview
11.1.7.2.2 Canada: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.3 Canada: Intravenous Immunoglobulin Market, by Type, 2019–2028 (US$ Million)
11.1.7.2.4 Canada: Intravenous Immunoglobulin Market, by Application, 2019–2028 (US$ Million)
11.1.7.2.5 Canada: Intravenous Immunoglobulin Market, by Distribution Channel, 2019–2028 (US$ Million)
11.1.7.2.6 Canada: Intravenous Immunoglobulin Market, by End User, 2019–2028 (US$ Million)
11.1.7.3 Mexico: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.1 Overview
11.1.7.3.2 Mexico: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.3 Mexico: Intravenous Immunoglobulin Market, by Type, 2019–2028 (US$ Million)
11.1.7.3.4 Mexico: Intravenous Immunoglobulin Market, by Application, 2019–2028 (US$ Million)
11.1.7.3.5 Mexico: Intravenous Immunoglobulin Market, by Distribution Channel, 2019–2028 (US$ Million)
11.1.7.3.6 Mexico: Intravenous Immunoglobulin Market, by End User, 2019–2028 (US$ Million)
11.2 Europe: Intravenous Immunoglobulin Market Revenue and Forecast to 2028
11.2.1 Overview
11.2.2 Europe: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
11.2.3 Europe: Intravenous Immunoglobulin Market, by Type, 2019–2028 (US$ Million)
11.2.4 Europe: Intravenous Immunoglobulin Market, by Application, 2019–2028 (US$ Million)
11.2.5 Europe: Intravenous Immunoglobulin Market, by Distribution Channel, 2019–2028 (US$ Million)
11.2.6 Europe: Intravenous Immunoglobulin Market, by End User, 2019–2028 (US$ Million)
11.2.7 Europe: Intravenous Immunoglobulin Market, by Country, 2022 & 2028 (%)
11.2.7.1 UK: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.1 Overview
11.2.7.1.2 UK: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.3 UK: Intravenous Immunoglobulin Market, by Type, 2019–2028 (US$ Million)
11.2.7.1.4 UK: Intravenous Immunoglobulin Market, by Application, 2019–2028 (US$ Million)
11.2.7.1.5 UK: Intravenous Immunoglobulin Market, by Distribution Channel, 2019–2028 (US$ Million)
11.2.7.1.6 UK: Intravenous Immunoglobulin Market, by End User, 2019–2028 (US$ Million)
11.2.7.2 Germany: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.1 Overview
11.2.7.2.2 Germany: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.3 Germany: Intravenous Immunoglobulin Market, by Type, 2019–2028 (US$ Million)
11.2.7.2.4 Germany: Intravenous Immunoglobulin Market, by Application, 2019–2028 (US$ Million)
11.2.7.2.5 Germany: Intravenous Immunoglobulin Market, by Distribution Channel, 2019–2028 (US$ Million)
11.2.7.2.6 Germany: Intravenous Immunoglobulin Market, by End User, 2019–2028 (US$ Million)
11.2.7.3 France: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.1 Overview
11.2.7.3.2 France: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.3 France: Intravenous Immunoglobulin Market, by Type, 2019–2028 (US$ Million)
11.2.7.3.4 France: Intravenous Immunoglobulin Market, by Application, 2019–2028 (US$ Million)
11.2.7.3.5 France: Intravenous Immunoglobulin Market, by Distribution Channel, 2019–2028 (US$ Million)
11.2.7.3.6 France: Intravenous Immunoglobulin Market, by End User, 2019–2028 (US$ Million)
11.2.7.4 Italy: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.1 Overview
11.2.7.4.2 Italy: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.3 Italy: Intravenous Immunoglobulin Market, by Type, 2019–2028 (US$ Million)
11.2.7.4.4 Italy: Intravenous Immunoglobulin Market, by Application, 2019–2028 (US$ Million)
11.2.7.4.5 Italy: Intravenous Immunoglobulin Market, by Distribution Channel, 2019–2028 (US$ Million)
11.2.7.4.6 Italy: Intravenous Immunoglobulin Market, by End User, 2019–2028 (US$ Million)
11.2.7.5 Spain: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.1 Overview
11.2.7.5.2 Spain: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.3 Spain: Intravenous Immunoglobulin Market, by Type, 2019–2028 (US$ Million)
11.2.7.5.4 Spain: Intravenous Immunoglobulin Market, by Application, 2019–2028 (US$ Million)
11.2.7.5.5 Spain: Intravenous Immunoglobulin Market, by Distribution Channel, 2019–2028 (US$ Million)
11.2.7.5.6 Spain: Intravenous Immunoglobulin Market, by End User, 2019–2028 (US$ Million)
11.2.7.6 Rest of Europe: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.1 Overview
11.2.7.6.2 Rest of Europe: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.3 Rest of Europe: Intravenous Immunoglobulin Market, by Type, 2019–2028 (US$ Million)
11.2.7.6.4 Rest of Europe: Intravenous Immunoglobulin Market, by Application, 2019–2028 (US$ Million)
11.2.7.6.5 Rest of Europe: Intravenous Immunoglobulin Market, by Distribution Channel, 2019–2028 (US$ Million)
11.2.7.6.6 Rest of Europe: Intravenous Immunoglobulin Market, by End User, 2019–2028 (US$ Million)
11.3 Asia Pacific: Intravenous Immunoglobulin Market Revenue and Forecast to 2028
11.3.1 Overview
11.3.2 Asia Pacific Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
11.3.3 Asia Pacific: Intravenous Immunoglobulin Market, By Type – 2019–2028 (US$ Million)
11.3.4 Asia Pacific: Intravenous Immunoglobulin Market, by Application – 2019–2028 (US$ Million)
11.3.5 Asia Pacific: Intravenous Immunoglobulin Market, By Distribution Channel – 2019–2028 (US$ Million)
11.3.6 Asia Pacific: Intravenous Immunoglobulin Market, by End User – 2019–2028 (US$ Million)
11.3.7 Asia Pacific: Intravenous Immunoglobulin Market, by Country, 2022 & 2028 (%)
11.3.7.1 China: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.1.1 Overview
11.3.7.1.2 China: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.1.3 China: Intravenous Immunoglobulin Market, By Type – 2019–2028 (US$ Million)
11.3.7.1.4 China: Intravenous Immunoglobulin Market, by Application – 2019–2028 (US$ Million)
11.3.7.1.5 China: Intravenous Immunoglobulin Market, By Distribution Channel – 2019–2028 (US$ Million)
11.3.7.1.6 China: Intravenous Immunoglobulin Market, by End User – 2019–2028 (US$ Million)
11.3.7.2 Japan: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.2.1 Overview
11.3.7.2.2 Japan: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.2.3 Japan: Intravenous Immunoglobulin Market, By Type – 2019–2028 (US$ Million)
11.3.7.2.4 Japan: Intravenous Immunoglobulin Market, by Application – 2019–2028 (US$ Million)
11.3.7.2.5 Japan: Intravenous Immunoglobulin Market, By Distribution Channel – 2019–2028 (US$ Million)
11.3.7.2.6 Japan: Intravenous Immunoglobulin Market, by End User – 2019–2028 (US$ Million)
11.3.7.3 India Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.3.1 Overview
11.3.7.3.2 India: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.3.3 India: Intravenous Immunoglobulin Market, By Type – 2019–2028 (US$ Million)
11.3.7.3.4 India: Intravenous Immunoglobulin Market, by Application – 2019–2028 (US$ Million)
11.3.7.3.5 India: Intravenous Immunoglobulin Market, By Distribution Channel – 2019–2028 (US$ Million)
11.3.7.3.6 India: Intravenous Immunoglobulin Market, by End User – 2019–2028 (US$ Million)
11.3.7.4 Australia: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.4.1 Overview
11.3.7.4.2 Australia: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.4.3 Australia: Intravenous Immunoglobulin Market, By Type – 2019–2028 (US$ Million)
11.3.7.4.4 Australia: Intravenous Immunoglobulin Market, by Application – 2019–2028 (US$ Million)
11.3.7.4.5 Australia: Intravenous Immunoglobulin Market, By Distribution Channel – 2019–2028 (US$ Million)
11.3.7.4.6 Australia: Intravenous Immunoglobulin Market, by End User – 2019–2028 (US$ Million)
11.3.7.5 South Korea: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.5.1 Overview
11.3.7.5.2 South Korea: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.5.3 South Korea: Intravenous Immunoglobulin Market, By Type – 2019–2028 (US$ Million)
11.3.7.5.4 South Korea: Intravenous Immunoglobulin Market, by Application – 2019–2028 (US$ Million)
11.3.7.5.5 South Korea: Intravenous Immunoglobulin Market, By Distribution Channel – 2019–2028 (US$ Million)
11.3.7.5.6 South Korea: Intravenous Immunoglobulin Market, by End User – 2019–2028 (US$ Million)
11.3.7.6 Rest of Asia Pacific: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
11.3.7.6.1 Overview
11.3.7.6.2 Rest of Asia Pacific: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
11.3.7.6.3 Rest of Asia Pacific: Intravenous Immunoglobulin Market, By Type – 2019–2028 (US$ Million)
11.3.7.6.4 Rest of Asia Pacific: Intravenous Immunoglobulin Market, by Application – 2019–2028 (US$ Million)
11.3.7.6.5 Rest of Asia Pacific: Intravenous Immunoglobulin Market, By Distribution Channel – 2019–2028 (US$ Million)
11.3.7.6.6 Rest of Asia Pacific: Intravenous Immunoglobulin Market, by End User – 2019–2028 (US$ Million)
11.4 South & Central America: Intravenous Immunoglobulin Market
11.4.1 Overview
11.4.2 South and Central America: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (USD Million)
11.4.3 South and Central America: Intravenous Immunoglobulin Market, by Type, 2019–2028 (USD Million)
11.4.4 South and Central America: Intravenous Immunoglobulin Market, by Application, 2019–2028 (USD Million)
11.4.5 South and Central America: Intravenous Immunoglobulin Market, by Distribution Channel, 2019–2028 (USD Million)
11.4.6 South and Central America: Intravenous Immunoglobulin Market, by End User, 2019–2028 (USD Million)
11.4.7 South and Central America: Intravenous Immunoglobulin Market, by Country, 2022 & 2028 (%)
11.4.7.1 Brazil: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.1.1 Overview
11.4.7.1.2 Brazil: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.1.3 Brazil: Intravenous Immunoglobulin Market, by Type, 2019–2028 (USD Million)
11.4.7.1.4 Brazil: Intravenous Immunoglobulin Market, by Application, 2019–2028 (USD Million)
11.4.7.1.5 Brazil: Intravenous Immunoglobulin Market, by Distribution Channel, 2019–2028 (USD Million)
11.4.7.1.6 Brazil: Intravenous Immunoglobulin Market, by End User, 2019–2028 (USD Million)
11.4.7.2 Argentina: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.2.1 Overview
11.4.7.2.2 Argentina: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.2.3 Argentina: Intravenous Immunoglobulin Market, by Type, 2019–2028 (USD Million)
11.4.7.2.4 Argentina: Intravenous Immunoglobulin Market, by Application, 2019–2028 (USD Million)
11.4.7.2.5 Argentina: Intravenous Immunoglobulin Market, by Distribution Channel, 2019–2028 (USD Million)
11.4.7.2.6 Argentina: Intravenous Immunoglobulin Market, by End User, 2019–2028 (USD Million)
11.4.7.3 Rest of South and Central America: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.3.1 Overview
11.4.7.3.2 Rest of South and Central America: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.3.3 Rest of South and Central America: Intravenous Immunoglobulin Market, by Type, 2019–2028 (USD Million)
11.4.7.3.4 Rest of South and Central America: Intravenous Immunoglobulin Market, by Application, 2019–2028 (USD Million)
11.4.7.3.5 Rest of South and Central America: Intravenous Immunoglobulin Market, by Distribution Channel, 2019–2028 (USD Million)
11.4.7.3.6 Rest of South and Central America: Intravenous Immunoglobulin Market, by End User, 2019–2028 (USD Million)
11.5 Middle East & Africa Intravenous Immunoglobulin Market
11.5.1 Overview
11.5.2 Middle East & Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
11.5.3 Middle East & Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, by Type (US$ Million)
11.5.4 Middle East & Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, by Application (US$ Million)
11.5.5 Middle East & Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, by Distribution Channel (US$ Million)
11.5.6 Middle East & Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, by End User (US$ Million)
11.5.7 Middle East & Africa Intravenous Immunoglobulin Market Revenue and Forecast to 2028, by Country (%)
11.5.7.1 Saudi Arabia: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (USD Million)
11.5.7.1.1 Overview
11.5.7.1.2 Saudi Arabia Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
11.5.7.1.3 Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)
11.5.7.1.4 Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Application (US$ Million)
11.5.7.1.5 Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Distribution Channel (US$ Million)
11.5.7.1.6 Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By End User (US$ Million)
11.5.7.2 South Africa: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (USD Million)
11.5.7.2.1 Overview
11.5.7.2.2 South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
11.5.7.2.3 South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)
11.5.7.2.4 South Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Application (US$ Million)
11.5.7.2.5 South Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Distribution Channel (US$ Million)
11.5.7.2.6 South Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By End User (US$ Million)
11.5.7.3 UAE: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (USD Million)
11.5.7.3.1 Overview
11.5.7.3.2 UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
11.5.7.3.3 UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)
11.5.7.3.4 UAE: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Application (US$ Million)
11.5.7.3.5 UAE: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Distribution Channel (US$ Million)
11.5.7.3.6 UAE: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By End User (US$ Million)
11.5.7.4 Rest of the Middle East and Africa: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (USD Million)
11.5.7.4.1 Overview
11.5.7.4.2 Rest of the Middle East and Africa Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
11.5.7.4.3 Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)
11.5.7.4.4 Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Application (US$ Million)
11.5.7.4.5 Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Distribution Channel (US$ Million)
11.5.7.4.6 Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By End User (US$ Million)
12. Impact of COVID-19 Pandemic on Intravenous Immunoglobulin Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 South and Central America: Impact Assessment of COVID-19 Pandemic
12.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
13. Intravenous Immunoglobulin Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Intravenous Immunoglobulin Market
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Takeda Pharmaceutical Company Limited
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Grifols, S.A.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Pfizer Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 ADMA Biologics, Inc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Bio Products Laboratory Ltd.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Shanghai RAAS
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Octapharma AG
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Kedrion S.p.A
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 CSL Behring (CSL Limited)
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Prothya Biosolutions B.V.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms in Intravenous Immunoglobulin Market
LIST OF TABLES
Table 1. North America Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America: Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 4. North America Intravenous Immunoglobulin Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 5. US Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. US Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 7. US Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 8. US Intravenous Immunoglobulin Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Intravenous Immunoglobulin Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Intravenous Immunoglobulin Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Europe Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. Europe: Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 19. Europe Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 20. Europe Intravenous Immunoglobulin Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. UK Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 22. UK: Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 23. UK Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 24. UK Intravenous Immunoglobulin Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 25. Germany Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 26. Germany: Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 27. Germany Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 28. Germany Intravenous Immunoglobulin Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 29. France Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 30. France: Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 31. France Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 32. France Intravenous Immunoglobulin Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 33. Italy Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 34. Italy: Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 35. Italy Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 36. Italy Intravenous Immunoglobulin Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 37. Spain Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 38. Spain: Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 39. Spain Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 40. Spain Intravenous Immunoglobulin Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 41. Rest of Europe Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 42. Rest of Europe: Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 43. Rest of Europe Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 44. Rest of Europe Intravenous Immunoglobulin Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 45. Asia Pacific: Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (US$ Million).
Table 46. Asia Pacific: Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 47. Asia Pacific: Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 48. Asia Pacific: Intravenous Immunoglobulin Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 49. China: Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (US$ Million).
Table 50. China: Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 51. China: Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 52. China: Intravenous Immunoglobulin Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 53. Japan: Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (US$ Million).
Table 54. Japan: Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 55. Japan: Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 56. Japan: Intravenous Immunoglobulin Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 57. India: Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (US$ Million).
Table 58. India: Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 59. India: Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 60. India: Intravenous Immunoglobulin Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 61. Australia: Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (US$ Million).
Table 62. Australia: Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 63. Australia: Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 64. Australia: Intravenous Immunoglobulin Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 65. South Korea: Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (US$ Million).
Table 66. South Korea: Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 67. South Korea: Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 68. South Korea: Intravenous Immunoglobulin Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 69. Rest of Asia Pacific: Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (US$ Million).
Table 70. Rest of Asia Pacific: Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 71. Rest of Asia Pacific: Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 72. Rest of Asia Pacific: Intravenous Immunoglobulin Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 73. South and Central America: Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 74. South and Central America: Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 75. South and Central America: Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 76. South and Central America: Intravenous Immunoglobulin Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 77. Brazil: Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 78. Brazil: Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 79. Brazil: Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 80. Brazil: Intravenous Immunoglobulin Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 81. Argentina: Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 82. Argentina: Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 83. Argentina: Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 84. Argentina: Intravenous Immunoglobulin Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 85. Rest of South and Central America: Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 86. Rest of South and Central America: Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 87. Rest of South and Central America: Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 88. Rest of South and Central America: Intravenous Immunoglobulin Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 89. Middle East & Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, by Type (US$ Million)
Table 90. Middle East & Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, by Application (US$ Million)
Table 91. Middle East & Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, by Distribution Channel (US$ Million)
Table 92. Middle East & Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, by End User (US$ Million)
Table 93. Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)
Table 94. Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Application (US$ Million)
Table 95. Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Distribution Channel (US$ Million)
Table 96. Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 97. South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)
Table 98. South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Application (US$ Million)
Table 99. South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Distribution Channel (US$ Million)
Table 100. South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 101. UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)
Table 102. UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Application (US$ Million)
Table 103. UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Distribution Channel (US$ Million)
Table 104. UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 105. Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)
Table 106. Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Application (US$ Million)
Table 107. Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Distribution Channel (US$ Million)
Table 108. Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 109. Recent Inorganic Growth Strategies in the Intravenous Immunoglobulin Market
Table 110. Recent Organic Growth Strategies in the Intravenous Immunoglobulin Market
Table 111. Glossary of Terms in Intravenous Immunoglobulin Market
LIST OF FIGURES
Figure 1. Intravenous Immunoglobulin Market Segmentation
Figure 2. Intravenous Immunoglobulin Market Segmentation, By Region
Figure 3. Global Intravenous Immunoglobulin Market Overview
Figure 4. IgG Segment Held Largest Share by Type in Intravenous Immunoglobulin Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Intravenous Immunoglobulin Market, By Geography (US$ Million)
Figure 7. Global Intravenous Immunoglobulin Market - Leading Country Markets (US$ Million)
Figure 8. Global Intravenous Immunoglobulin Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. South & Central America: PEST Analysis
Figure 13. Middle East & Africa: PEST Analysis
Figure 14. Impact Analysis
Figure 15. Global Intravenous Immunoglobulin Market– Revenue Forecast and Analysis – 2020 - 2028
Figure 16. Global Intravenous Immunoglobulin Market – By Geography Forecast and Analysis – 2022 - 2028
Figure 17. Global Intravenous Immunoglobulin Market – Market Potential Analysis, By Region
Figure 18. Global Intravenous Immunoglobulin Market – Comparative Company Analysis
Figure 19. Global Intravenous Immunoglobulin Market – Growth Strategy Analysis
Figure 20. Market Positioning of Key Players in Intravenous Immunoglobulin Market
Figure 21. Global Intravenous Immunoglobulin Market, by Type 2022 & 2028 (%)
Figure 22. IgG Revenue and Forecasts to 2028 (US$ Million)
Figure 23. IgM - Revenue and Forecasts to 2028 (US$ Million)
Figure 24. IgA - Revenue and Forecasts to 2028 (US$ Million)
Figure 25. IgE - Revenue and Forecasts to 2028 (US$ Million)
Figure 26. IgD - Revenue and Forecasts to 2028 (US$ Million)
Figure 27. Global Intravenous Immunoglobulin Market, by Application 2022 & 2028 (%)
Figure 28. Hypogammaglobulinemia - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. Chronic Inflammatory Demyelinating Polyneuropathy - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 30. Immunodeficiency Diseases - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 31. Myasthenia Gravis - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 32. Multifocal Motor Neuropathy - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 33. Idiopathic Thrombocytopenic Purpura - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 34. Inflammatory Myopathies - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 35. Specific Antibody Deficiency - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 36. Guillain-Barre Syndrome - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 37. Others - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 38. Global Intravenous Immunoglobulin Market, by Distribution Channel 2022 & 2028 (%)
Figure 39. Hospital Pharmacy - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 40. Retail Pharmacy - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 41. Others - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 42. Global Intravenous Immunoglobulin Market, by End User 2022 & 2028 (%)
Figure 43. Hospitals - Market Revenue And Forecasts To 2028 (US$ Million)
Figure 44. Specialty Clinics - Market Revenue And Forecasts To 2028 (US$ Million)
Figure 45. Others- Market Revenue And Forecasts To 2028 (US$ Million)
Figure 46. North America: Intravenous Immunoglobulin Market, by Key Country – Revenue (2022) (US$ Million)
Figure 47. North America Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
Figure 48. North America: Intravenous Immunoglobulin Market, by Country, 2022 & 2028 (%)
Figure 49. US: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 50. Canada: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 51. Mexico: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 52. Europe: Intravenous Immunoglobulin Market, by Key Country – Revenue (2022) (US$ Million)
Figure 53. Europe Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
Figure 54. Europe: Intravenous Immunoglobulin Market, by Country, 2022 & 2028 (%)
Figure 55. UK: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 56. Germany: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 57. France: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 58. Italy: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 59. Spain: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 60. Rest of Europe: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 61. Asia Pacific Intravenous Immunoglobulin Market Overview, by Country (2022)
Figure 62. Asia Pacific: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
Figure 63. Asia Pacific: Intravenous Immunoglobulin Market, by Country, 2022 & 2028 (%)
Figure 64. China: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
Figure 65. Japan: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
Figure 66. India: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
Figure 67. Australia: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
Figure 68. South Korea: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
Figure 69. Rest of Asia Pacific: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 70. South and Central America: Intravenous Immunoglobulin Market, by Key Country – Revenue (2022) (USD Million)
Figure 71. South and Central America Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (USD Million)
Figure 72. South and Central America: Intravenous Immunoglobulin Market, by Country, 2022 & 2028 (%)
Figure 73. Brazil: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (USD Million)
Figure 74. Argentina: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (USD Million)
Figure 75. Rest of South and Central America: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (USD Million)
Figure 76. Middle East & Africa Intravenous Immunoglobulin Market Revenue Overview, by Country, 2022 (US$ Million)
Figure 77. Middle East & Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
Figure 78. Middle East & Africa Intravenous Immunoglobulin Market Revenue and Forecast to 2028, by Country (%)
Figure 79. Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
Figure 80. South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
Figure 81. UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
Figure 82. Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
Figure 83. Impact of COVID-19 Pandemic on North America Countries
Figure 84. Impact of COVID-19 Pandemic on European Countries
Figure 85. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 86. Impact of COVID-19 Pandemic in South and Central American Countries
Figure 87. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 88. Growth Strategies in the Intravenous Immunoglobulin Market
The List of Companies - Intravenous Immunoglobulin Market
- Takeda Pharmaceutical Company Limited
- Grifols, S.A.
- Pfizer Inc.
- ADMA Biologics Inc.
- Bio Products Laboratory Ltd.
- Shanghai RAAS
- Octapharma AG
- Kedrion S.p.A
- CSL Behring (CSL Limited)
- Prothya Biosolutions B.V.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For